Date published: 2026-7-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBL2 Activators

The class of chemicals known as FBL2 Activators is not a formal designation, but rather a grouping based on their potential to indirectly influence the activity of FBXL2, a protein that plays a role in ubiquitination and protein degradation. These chemicals function by impacting various aspects of protein regulation, degradation, and cellular signaling pathways, which can ultimately influence the activity of FBXL2. The influence of these chemicals on FBXL2 is indirect and hinges on their ability to modify the cellular environment in which FBXL2 operates. For instance, proteasome inhibitors like MG132, Epoxomicin, and Bortezomib prevent the degradation of ubiquitin-tagged proteins, thereby increasing overall ubiquitination levels and potentially influencing FBXL2's activity. Similarly, inhibitors of protein synthesis and ERAD, like Cycloheximide and Eeyarestatin I respectively, disrupt the pool of proteins available for ubiquitination and degradation, which can also indirectly influence FBXL2.

Other chemicals in this grouping, like MLN4924, Leptomycin B, and Chloroquine, target more specific aspects of cellular function. MLN4924, an inhibitor of the NEDD8-activating enzyme, affects the neddylation process crucial for cullin-RING ligases, a complex that FBXL2 is part of. Leptomycin B, an inhibitor of CRM1/exportin 1, affects the subcellular localization of proteins, which can influence FBXL2. Chloroquine, an autophagy inhibitor, can affect the degradation of proteins, indirectly influencing FBXL2. Furthermore, inhibitors of cellular growth and proliferation signals, such as Torin 1, LY294002, PD98059, and Rapamycin, can indirectly influence FBXL2 by modifying the signaling environment in which FBXL2 operates. For example, Torin 1 and Rapamycin, both mTOR inhibitors, and LY294002, a PI3K inhibitor, can affect cellular growth signals and thereby possibly influence FBXL2 activity. PD98059, an MEK inhibitor, influences the MAPK pathway and can alter cellular growth and proliferation signals, potentially influencing FBXL2 activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Another proteasome inhibitor that works similarly to MG132. By inhibiting proteasome activity, it can indirectly influence FBXL2 activity.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

An inhibitor of protein synthesis, affecting the pool of proteins available for ubiquitination and degradation, possibly influencing FBXL2's activity.

Eeyarestatin I

412960-54-4sc-358130B
sc-358130
sc-358130A
sc-358130C
sc-358130D
sc-358130E
5 mg
10 mg
25 mg
50 mg
100 mg
500 mg
$114.00
$203.00
$354.00
$697.00
$1363.00
$5836.00
12
(1)

An inhibitor of ER-associated degradation (ERAD) that disrupts protein degradation and can indirectly influence FBXL2.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

An inhibitor of NEDD8-activating enzyme, it affects the neddylation process, which is crucial for the function of cullin-RING ligases (CRLs), indirectly affecting FBXL2.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

An inhibitor of CRM1/exportin 1, it affects nuclear export, indirectly influencing the subcellular localization and activity of FBXL2.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

An autophagy inhibitor that can affect the degradation of proteins, indirectly influencing FBXL2.

Torin 1

1222998-36-8sc-396760
10 mg
$245.00
7
(1)

An mTOR inhibitor, it can affect cellular growth and proliferation signals, indirectly influencing FBXL2.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An MEK inhibitor that influences the MAPK pathway, altering cellular growth and proliferation signals, potentially influencing FBXL2 activity.